STOCK TITAN

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025

Novavax (NVAX) has announced it will host a conference call on Thursday, February 27, 2025, at 8:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results and operational highlights.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings date

Novavax (NVAX) has announced it will host a conference call on Thursday, February 27, 2025, at 8:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results and operational highlights. The company, which specializes in protein-based vaccines with its Matrix-M™ adjuvant technology, will provide participants with options to join the call either through automated registration or operator assistance.

Loading...
Loading translation...
Argus Session date unavailable
-1.25% session move Open Argus
Details

News Market Reaction – NVAX

The recorded move for NVAX in the trading session of this news was -1.25%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

GAITHERSBURG, Md., Feb. 20, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 27, 2025. Details of the event and replay are as follows:

Conference call details:


Date:

February 27, 2025

Time:

8:30 a.m. U.S. ET

URL to register phone:

https://emportal.ink/3PsP11e

Dial-in number:

(800) 836-8184 (Domestic) or


(+1) (646) 357-8785 (International)

Webcast:

  ir.novavax.com/events

  • Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
  • Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
  • To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:


Date:

Available starting at 11:30 a.m. U.S. ET, February 27, 2025, until 11:59 p.m. U.S. ET, March 6, 2025

Dial-in number:

(888) 660-6345 (Domestic) or


(+1) (646) 517-4150 (International)

Passcode:

79349#

Webcast:

ir.novavax.com/events, until March 29, 2025

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

Novavax Logo (PRNewsfoto/Novavax)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025-302381190.html

SOURCE Novavax, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Novavax (NVAX) report Q4 and full year 2024 earnings?

Novavax will report its Q4 and full year 2024 financial results on Thursday, February 27, 2025, at 8:30 a.m. Eastern Time.

How can investors join the Novavax (NVAX) Q4 2024 earnings call?

Investors can join either through automated registration with their phone number for an automatic callback or by dialing in directly to be connected by an operator.

What will be discussed in Novavax's (NVAX) February 27 conference call?

The conference call will cover Novavax's fourth quarter and full year 2024 financial results and operational highlights.

What time should participants join the Novavax (NVAX) earnings call?

Participants are recommended to join at least 10 minutes prior to the scheduled webcast time of 8:30 a.m. ET.

Keep reading